Atlas Trials

Dose-range Finding Study of BF2.649 Effect on Patients With Obstructive Sleep Apnea (OSA)

Clinical trial NCT01620554 · COMPLETED

Trial details

NCT number
NCT01620554
Sponsor
Bioprojet
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Obstructive Sleep ApnoeaExcessive Daytime Sleepiness
Start date
2010-10-01
Primary completion
2011-12-01
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.